{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T05:06:45Z","timestamp":1793509605192,"version":"4.5.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1053\/j.seminhematol.2018.05.016","type":"journal-article","created":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T19:53:13Z","timestamp":1529783593000},"page":"69-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Acquired and germline predisposition to bone marrow failure: Diagnostic features and clinical implications"],"prefix":"10.1053","volume":"56","author":[{"given":"Michael E.","family":"Kallen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Dulau-Florea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R.","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2018.05.016_bib0001","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1182\/blood-2006-03-010777","article-title":"Current concepts in the pathophysiology and treatment of aplastic anemia","volume":"108","author":"Young","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0002","unstructured":"Diagnostic pediatric hematopathology: Cambridge University Press; 2011."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0003","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1056\/NEJM199704103361504","article-title":"Hepatitis-associated aplastic anemia","volume":"336","author":"Brown","year":"1997","journal-title":"N Engl J Med."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0004","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJM198203253061204","article-title":"Aplastic anemia (second of two parts): pathogenesis, diagnosis, treatment, and prognosis","volume":"306","author":"Camitta","year":"1982","journal-title":"N Engl J Med."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1634\/theoncologist.2014-0056","article-title":"The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failure","volume":"19","author":"DeZern","year":"2014","journal-title":"Oncologist"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0006","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2011-12-274019","article-title":"How I treat acquired aplastic anemia","volume":"120","author":"Scheinberg","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0007","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3324\/haematol.13755","article-title":"Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach","volume":"94","author":"Bennett","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0008","unstructured":"Swerdlow SH, Campo E, Harris NL, et al. WHO Classification classification of Tumours tumours of Haematopoietic haematopoietic and Lymphoid lymphoid Tissuestissues. 2017."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0009","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2141.1994.tb04903.x","article-title":"Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure","volume":"87","author":"Maciejewski","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0010","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(05)66515-4","article-title":"Aplastic anaemia","volume":"365","author":"Brodsky","year":"2005","journal-title":"The Lancet"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0011","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJM199705083361906","article-title":"The pathophysiology of acquired aplastic anemia","volume":"336","author":"Young","year":"1997","journal-title":"N Engl J Med."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0012","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V99.9.3129","article-title":"Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia","volume":"99","author":"Maciejewski","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0013","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1414799","article-title":"Somatic mutations and clonal hematopoiesis in aplastic anemia","volume":"373","author":"Yoshizato","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0014","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0015","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1182\/blood-2015-08-667063","article-title":"MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance","volume":"126","author":"Kwok","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0016","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","article-title":"Eltrombopag added to standard immunosuppression for aplastic anemia","volume":"376","author":"Townsley","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0017","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1200931","article-title":"Eltrombopag and improved hematopoiesis in refractory aplastic anemia","volume":"367","author":"Olnes","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0018","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MOH.0000000000000281","article-title":"Hematopoietic stem cell transplantation for acquired aplastic anemia","volume":"23","author":"Georges","year":"2016","journal-title":"Curr Opin Hematol."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0019","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.seminoncol.2011.04.006","article-title":"Immunologic aspects of hypoplastic myelodysplastic syndrome","volume":"38","author":"Calado","year":"2011","journal-title":"Semin Oncol."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1182\/asheducation-2011.1.84","article-title":"Classification of childhood aplastic anemia and myelodysplastic syndrome","volume":"2011","author":"Niemeyer","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0021","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07593.x","article-title":"IL-17-producing CD4(+) T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome","volume":"145","author":"Kordasti","year":"2009","journal-title":"Br J Haematol."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0022","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/sj.leu.2404119","article-title":"Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes","volume":"20","author":"Matsui","year":"2006","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0023","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/leu.2012.30","article-title":"Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group","volume":"26","author":"Westers","year":"2012","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0024","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3324\/haematol.2014.107706","article-title":"Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood","volume":"100","author":"Aalbers","year":"2015","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0025","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0026","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0027","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0037-1963(03)00133-1","article-title":"Clinical features of large granular lymphocyte leukemia","volume":"40","author":"Lamy","year":"2003","journal-title":"Semin Hematol."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0028","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood.V98.2.483","article-title":"Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes","volume":"98","author":"Go","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0029","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1182\/blood.V96.10.3644","article-title":"Lymphoproliferative disease of granular T lymphocytes presenting as aplastic anemia","volume":"96","author":"Go","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0030","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V99.1.268","article-title":"Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B","volume":"99","author":"Morice","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0031","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0002-9440(10)63032-5","article-title":"Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)\/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease","volume":"159","author":"Lima","year":"2001","journal-title":"Am J Pathol."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0032","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1182\/blood.V99.10.3668","article-title":"Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens","volume":"99","author":"Kook","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0033","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.leu.2403617","article-title":"Large granular lymphocyte (LGL)-like clonal expansions in paroxysmal nocturnal hemoglobinuria (PNH) patients","volume":"19","author":"Risitano","year":"2005","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0034","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0035","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2005-08-3076","article-title":"Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis","volume":"107","author":"Schade","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0036","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood-2016-06-724856","article-title":"High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia","volume":"128","author":"Andersson","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0037","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood-2009-03-208629","article-title":"Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia","volume":"115","author":"Vinh","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0038","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0039","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0040","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ng.923","article-title":"Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)","volume":"43","author":"Ostergaard","year":"2011","journal-title":"Nat Genet."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0041","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ng.913","article-title":"Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia","volume":"43","author":"Hahn","year":"2011","journal-title":"Nat Genet."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0042","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0043","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1093\/nar\/gks281","article-title":"Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies","volume":"40","author":"Bresnick","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0044","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1182\/blood-2012-08-452763","article-title":"GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome","volume":"121","author":"Hsu","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0045","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-07-517151","article-title":"The evolution of cellular deficiency in GATA2 mutation","volume":"123","author":"Dickinson","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0046","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3324\/haematol.2011.041152","article-title":"Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications","volume":"96","author":"Calvo","year":"2011","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0047","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood-2014-06-580340","article-title":"GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia","volume":"125","author":"Ganapathi","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0048","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.3324\/haematol.2012.063396","article-title":"MonoMAC and GATA2 deficiency: overlapping clinical and pathological features with aplastic anemia and idiopathic CD4+ lymphocytopenia. Reply to Haematologica 2012;97(4):058669","volume":"97","author":"Calvo","year":"2012","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0049","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3324\/haematol.2011.058669","article-title":"MonoMAC versus idiopathic CD4+lymphocytopenia. Comment to Haematologica. 2011;96(8):1221\u20135","volume":"97","author":"Chu","year":"2012","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0050","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3324\/haematol.2013.090217","article-title":"Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation","volume":"99","author":"West","year":"2014","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0051","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2011-06-365049","article-title":"Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency","volume":"118","author":"Cuellar-Rodriguez","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2018.05.016_bib0052","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.bbmt.2018.01.030","article-title":"Allogeneic hematopoietic stem cell transplantation for GATA2 deficiency using a Busulfan-Based regimen","volume":"24","author":"Parta","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0053","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrg3246","article-title":"The telomere syndromes","volume":"13","author":"Armanios","year":"2012","journal-title":"Nat Rev Genet."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0054","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMra0903373","article-title":"Telomere diseases","volume":"361","author":"Calado","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0055","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1182\/blood-2014-05-526285","article-title":"Bone marrow failure and the telomeropathies","volume":"124","author":"Townsley","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0056","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.hoc.2009.01.003","article-title":"Dyskeratosis congenita","volume":"23","author":"Savage","year":"2009","journal-title":"Hematol Oncol Clin N Am."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0057","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2000.02109.x","article-title":"Dyskeratosis congenita in all its forms","volume":"110","author":"Dokal","year":"2000","journal-title":"Br J Haematol."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0058","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00439-013-1265-8","article-title":"Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita","volume":"132","author":"Ballew","year":"2013","journal-title":"Hum Genet."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0059","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ajhg.2013.02.001","article-title":"Constitutional mutations in RTEL1 cause severe dyskeratosis congenita","volume":"92","author":"Walne","year":"2013","journal-title":"Am J Hum Genet."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ajhg.2007.10.004","article-title":"TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita","volume":"82","author":"Savage","year":"2008","journal-title":"Am J Hum Genet."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0061","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1182\/blood-2008-12-192880","article-title":"Cancer in dyskeratosis congenita","volume":"113","author":"Alter","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0062","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113747","article-title":"Direct comparison of flow-FISH and qPCR as diagnostic tests for telomere length measurement in humans","volume":"9","author":"Gutierrez-Rodrigues","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0063","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jama.2010.897","article-title":"Telomere length and risk of incident cancer and cancer mortality","volume":"304","author":"Willeit","year":"2010","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0064","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.2010.1376","article-title":"Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia","volume":"304","author":"Scheinberg","year":"2010","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3324\/haematol.2014.114389","article-title":"Telomere length in inherited bone marrow failure syndromes","volume":"100","author":"Alter","year":"2015","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0066","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood-2014-10-607572","article-title":"Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia","volume":"125","author":"Dumitriu","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0067","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/blood-2008-09-178871","article-title":"Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells","volume":"114","author":"Calado","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0068","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1056\/NEJMoa1515319","article-title":"Danazol treatment for telomere diseases","volume":"374","author":"Townsley","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0069","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1182\/blood-2016-01-583625","article-title":"How i treat MDS and AML in Fanconi anemia","volume":"127","author":"Peffault de Latour","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.blre.2010.03.002","article-title":"Pathophysiology and management of inherited bone marrow failure syndromes","volume":"24","author":"Shimamura","year":"2010","journal-title":"Blood Rev."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0071","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1586\/ehm.12.48","article-title":"Current clinical management of Fanconi anemia","volume":"5","author":"Smith","year":"2012","journal-title":"Expert Rev Hematol."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0072","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMra0809889","article-title":"Susceptibility pathways in Fanconi's anemia and breast cancer","volume":"362","author":"D'Andrea","year":"2010","journal-title":"N Engl J Med."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0073","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ncb879","article-title":"Interaction of FANCD2 and NBS1 in the DNA damage response","volume":"4","author":"Nakanishi","year":"2002","journal-title":"Nat Cell Biol."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0074","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1128\/MCB.23.10.3417-3426.2003","article-title":"A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome","volume":"23","author":"Meetei","year":"2003","journal-title":"Mol Cell Biol."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2013-09-427740","article-title":"Why does the bone marrow fail in Fanconi anemia","volume":"123","author":"Garaycoechea","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0076","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2141.2010.08078.x","article-title":"Haematopoeitic cell transplantation for Fanconi anaemia - when and how?","volume":"149","author":"MacMillan","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0077","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1182\/blood-2015-02-626002","article-title":"Alternative donor hematopoietic cell transplantation for Fanconi anemia","volume":"125","author":"MacMillan","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0078","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1182\/blood-2004-04-1652","article-title":"Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants","volume":"105","author":"Rosenberg","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0079","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2014-04-526301","article-title":"Marrow failure: a window into ribosome biology","volume":"124","author":"Ruggero","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0080","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood-2007-02-075184","article-title":"The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA","volume":"110","author":"Ganapathi","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0081","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1182\/blood-2012-04-420166","article-title":"Impaired ribosomal subunit association in Shwachman-Diamond syndrome","volume":"120","author":"Burwick","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0082","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood-2007-03-080044","article-title":"Mutations in the SBDS gene in acquired aplastic anemia","volume":"110","author":"Calado","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0083","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1046\/j.1365-2141.2002.03913.x","article-title":"Bone marrow failure in Shwachman-Diamond syndrome does not select for clonal haematopoiesis of the paroxysmal nocturnal haemoglobinuria phenotype","volume":"119","author":"Keller","year":"2002","journal-title":"Brit J Haematol"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0084","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2141.1997.3673181.x","article-title":"Adult onset of acute myeloid leukaemia (M6) in patients with Shwachman-Diamond syndrome","volume":"99","author":"Dokal","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0085","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/pbc.20478","article-title":"Shwachman-Diamond syndrome","volume":"45","author":"Dror","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0086","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood-2017-08-801985","article-title":"Somatic mutations and clonal hematopoiesis in congenital neutropenia","volume":"131","author":"Xia","year":"2018","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0087","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1365-2141.2008.07269.x","article-title":"Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference","volume":"142","author":"Vlachos","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0088","article-title":"Adenosine deaminase 2 deficiency as a cause of pure red cell aplasia mimicking Diamond Blackfan anemia","volume":"126","author":"Sasa","year":"2015","journal-title":"American Society of Hematology 2015 annual meeting abstract #3615, Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0089","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2010-02-251090","article-title":"How I treat Diamond-Blackfan anemia","volume":"116","author":"Vlachos","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0090","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood-2011-08-375972","article-title":"Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry","volume":"119","author":"Vlachos","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0091","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1073\/pnas.96.6.3132","article-title":"Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia","volume":"96","author":"Ihara","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0092","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood.V97.1.139","article-title":"c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia","volume":"97","author":"Ballmaier","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0093","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1182\/bloodadvances.2018016501","article-title":"MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia","volume":"2","author":"Germeshausen","year":"2018","journal-title":"Blood Adv."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0094","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/j.seminhematol.2016.11.003","article-title":"Recognition of familial myeloid neoplasia in adults","volume":"54","author":"Brown","year":"2017","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.seminhematol.2017.04.006","article-title":"RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM)","volume":"54","author":"Schlegelberger","year":"2017","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0096","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1182\/blood-2011-02-336537","article-title":"Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families","volume":"117","author":"Noris","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0097","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.3177","article-title":"Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy","volume":"47","author":"Zhang","year":"2015","journal-title":"Nat Genet."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0098","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3324\/haematol.2017.167726","article-title":"Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation","volume":"102","author":"Kanagal-Shamanna","year":"2017","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0099","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ng.3253","article-title":"Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia","volume":"47","author":"Noetzli","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0100","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1111\/jth.13855","article-title":"Inherited thrombocytopenia caused by ANKRD26 mutations misdiagnosed and treated as myelodysplastic syndrome: report on two cases","volume":"15","author":"Zaninetti","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0101","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0022-3476(97)70068-4","article-title":"High incidence of significant bone loss in patients with severe congenital neutropenia (Kostmann's syndrome)","volume":"131","author":"Yakisan","year":"1997","journal-title":"J Pediatr."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0102","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0140-6736(02)11201-3","article-title":"Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study","volume":"360","author":"P\u00fctsep","year":"2002","journal-title":"The Lancet"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0103","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/ACI.0b013e3282f1d690","article-title":"Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil?","volume":"7","author":"Schaffer","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0104","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2141.2009.07888.x","article-title":"Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia","volume":"147","author":"Xia","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0105","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1182\/blood-2013-11-535419","article-title":"Inherited biallelic CSF3R mutations in severe congenital neutropenia","volume":"123","author":"Triot","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0106","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev-immunol-030409-101259","article-title":"Genetic defects in severe congenital neutropenia: emerging insights into life and death of human neutrophil granulocytes","volume":"29","author":"Klein","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0107","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1149","article-title":"Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease","volume":"34","author":"Hernandez","year":"2003","journal-title":"Nat Genet."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0108","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood-2013-11-538025","article-title":"Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis","volume":"123","author":"Skokowa","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0109","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2010.08216.x","article-title":"Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy","volume":"150","author":"Rosenberg","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0110","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0111","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0112","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.270.5238.985","article-title":"Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4","volume":"270","author":"Waterhouse","year":"1995","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0113","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ajhg.2012.04.015","article-title":"Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity","volume":"90","author":"Lopez-Herrera","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0114","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood-2016-04-712612","article-title":"CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency","volume":"128","author":"Lo","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2018.05.016_bib0115","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2017-09-806489","article-title":"A landscape of germline mutations in a cohort of inherited bone marrow failure patients","volume":"131","author":"Bluteau","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2018.05.016_bib0116","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3324\/haematol.2017.180778","article-title":"Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7","volume":"103","author":"Pastor","year":"2017","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0117","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s41467-017-01590-5","article-title":"The genomic landscape of pediatric myelodysplastic syndromes","volume":"8","author":"Schwartz","year":"2017","journal-title":"Nat Commun."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0118","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0119","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/rheumatology\/kev439","article-title":"Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations","volume":"55","author":"Van Montfrans JM","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0120","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jaci.2016.03.016","article-title":"Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: successful hematopoietic stem cell transplantation","volume":"138","author":"Hsu","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"10.1053\/j.seminhematol.2018.05.016_bib0121","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ajhg.2012.03.020","article-title":"Exome sequencing identifies autosomal-dominant SRP72 mutations associated with familial aplasia and myelodysplasia","volume":"90","author":"Kirwan","year":"2012","journal-title":"Am J Hum Genet"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196318300660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196318300660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:25:52Z","timestamp":1758522352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196318300660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":121,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0037196318300660"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2018.05.016","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired and germline predisposition to bone marrow failure: Diagnostic features and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2018.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}